Cognex insider filing: 10,532 shares to be sold

Cognex insider filing reports an intended sale of 10,532 shares of common stock under Rule 144.

Rhea-AI Filing Summary

Cognex insider filing reports an intended sale of 10,532 shares of common stock under Rule 144. The filing lists aggregate value $590,107.96 and states shares outstanding were 165,707,920 as of 02/23/2026.

The excerpt also reports prior 10b5-1 sales by Carl W. Gerst III on 02/20/2026 of 3,804 shares for $212,979.49. Timing and method for the 10,532-share disposition are set out in the notice.

Insights

Corporate Governance Specialist

Routine Rule 144 sale by an insider; prior 10b5-1 transactions are disclosed.

The filing lists an intended sale of 10,532 shares and shows shares outstanding were 165,707,920 as of 02/23/2026. This is a standard disclosure under Rule 144 to report restricted or control stock dispositions.

Execution depends on the seller's plan and any 10b5-1 schedule; prior 10b5-1 sales on 02/20/2026 of 3,804 shares for $212,979.49 are included and may indicate prior staged sales. Subsequent filings will show actual trade execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Cognex (CGNX) Form 144 report?

It reports an intended sale of 10,532 shares of common stock under Rule 144. The filing lists aggregate value $590,107.96 and references 02/23/2026 for the shares outstanding figure.

Who previously sold shares according to the filing?

Carl W. Gerst III executed 10b5-1 sales on 02/20/2026 of 3,804 shares. The filing shows proceeds from those sales totaling $212,979.49.

How many Cognex shares were outstanding per the filing?

The filing lists shares outstanding as 165,707,920 as of 02/23/2026. This number is presented alongside the intended Rule 144 sale and aggregate value in the notice.

Is the 10,532-share amount a completed sale?

No—Form 144 reports the intended disposition of 10,532 shares under Rule 144. Completion and exact execution details are disclosed in subsequent trading or Form 4/5 filings if executed.

What was the aggregate value associated with the intended sale?

The filing lists an aggregate value of $590,107.96 for the 10,532 shares. That value appears on the same line that specifies the shares to be sold under the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001829813
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COGNEX CORPORATION
SEC File Number	001-34218
Address of Issuer	One Vision Drive Natick MASSACHUSETTS 01760
Phone	5086503000
Name of Person for Whose Account the Securities are To Be Sold	CARL W GERST III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10532	590107.96	165707920	02/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Restricted Stock Units	Issuer			10532	02/20/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CARL W GERST III One Vision Drive Natick MA 01760	Common	02/20/2026	3804	212979.49

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 02/20/2026 through 02/21/2026.
Date of Notice	02/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Carl William Gerst III
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)